Apax Partners to acquire a majority stake in Vitaprotech from Eurazeo.

Apax Partners, a private equity firm, agreed to acquire a majority stake in Vitaprotech, a provider of premium security solutions for sensitive sites, from Eurozeo, a private equity fund. Financial terms were not disclosed. “We are delighted to welcome the support of Apax by our side to write the next chapter in the development of Vitaprotech. The sector expertise of the fund and the quality of its teams convinced us to have them by our side, after having benefited from the support of the teams at Eurazeo over the past four years,” Eric Thord, Vitaprotech CEO.